New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 25, 2013
06:33 EDTIMGNImmunoGen says T-DM1 marketing application under review in U.S, Europe
ImmunoGen expects to reports clinical findings for three compounds and expects to advance its fourth compound, IMGN289, into clinical testing.
News For IMGN From The Last 14 Days
Check below for free stories on IMGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for IMGN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use